NWAM LLC’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
1,024,479
+24,128
| +2% | +$270K | 0.93% | 17 |
|
|
2025
Q1 | $8.58M | Buy |
1,000,351
+87,300
| +10% | +$749K | 0.74% | 19 |
|
|
2024
Q4 | $9.81M | Buy |
913,051
+2,575
| +0.3% | +$27.7K | 0.61% | 36 |
|
|
2024
Q3 | $5.17M | Buy |
+910,476
| New | +$5.17M | 0.32% | 75 |
|
|
2024
Q2 | – | Sell |
-836,730
| Closed | -$3.21M | – | 180 |
|
|
2024
Q1 | $3.21M | Buy |
836,730
+38,437
| +5% | +$148K | 0.26% | 86 |
|
|
2023
Q4 | $7.43M | Buy |
798,293
+77,303
| +11% | +$720K | 0.6% | 30 |
|
|
2023
Q3 | $4.72M | Buy |
720,990
+86,390
| +14% | +$566K | 0.48% | 43 |
|
|
2023
Q2 | $5.16M | Buy |
634,600
+86,363
| +16% | +$702K | 0.42% | 51 |
|
|
2023
Q1 | $4.7M | Buy |
+548,237
| New | +$4.7M | 0.48% | 47 |
|